Amulet Capital Partners, LP (a middle-market private equity investment firm focused on the healthcare sector) announced the closing of Amulet Capital Fund III with about $1.2 billion in capital commitments.
This oversubscribed fund represents commitments from a diverse range of global institutional investors, including state and corporate pension funds, endowments, foundations and family offices. Following the close, Amulet now manages about $2.7 billion in assets.
Building on Amulet’s the firm’s value-oriented and thesis-driven investment strategy and successful track record, Fund III will continue to partnering with strong businesses across high-conviction and high-growth subsectors within the broader life sciences outsourcing, healthcare provider and payor and payor services ecosystems. And Amulet’s flexibility and creativity in personalizing its investment approach to each portfolio company partnership underpins the firm’s ability to work with management teams to execute on a shared vision for creating long-term value.
Amulet has completed two new platform investments in Fund III, partnering with minds + assembly, a full-service, design-centric agency and commercialization platform servicing the pharmaceutical, biotech and digital health industries; and Alliance Clinical Network – which is a leading comprehensive clinical platform serving patients, pharmaceutical sponsors and CROs across numerous clinical areas, including dermatology, gastroenterology, neurology, pain, vaccines and women’s health.
Capstone Partners (a Mizuho Company) acted as exclusive placement agent for Fund III, and Kirkland & Ellis acted as legal counsel to Amulet.
KEY QUOTES:
“We are grateful to have received such strong support from our existing and new investors and are pleased to have closed Fund III significantly above target. This marks the third consecutive above-target raise for our firm, which we view as a testament to our consistent investment philosophy and the strength of the value-creation framework we’ve built and successfully implemented across our portfolio consistently throughout cycles.”
- Ramsey Frank, President and Managing Partner of Amulet
“This successful capital raise reflects the deep expertise of our team, network and track record of delivering positive outcomes. We believe the unique – and often underinvested – subsectors we’ve identified represent significant opportunity for Fund III. We are excited to continue strategically deploying capital to help build best-in-class businesses and drive meaningful change and innovation for patients, physicians and the broader healthcare landscape across the country.”
- Jay Rose, Managing Partner of Amulet
